124 related articles for article (PubMed ID: 6141730)
1. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
Schoene RB; Abuan T; Ward RL; Beasley CH
Am J Ophthalmol; 1984 Jan; 97(1):86-92. PubMed ID: 6141730
[TBL] [Abstract][Full Text] [Related]
2. The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects.
Dunn TL; Gerber MJ; Shen AS; Fernandez E; Iseman MD; Cherniack RM
Am Rev Respir Dis; 1986 Feb; 133(2):264-8. PubMed ID: 3946922
[TBL] [Abstract][Full Text] [Related]
3. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
Höh H
Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
[No Abstract] [Full Text] [Related]
4. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Diggory P; Cassels-Brown A; Fernandez C
Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
Dorigo MT; Cerin O; Fracasso G; Altafini R
Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
[TBL] [Abstract][Full Text] [Related]
8. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
Spiritus EM; Casciari R
Am J Ophthalmol; 1985 Sep; 100(3):492-4. PubMed ID: 4037047
[No Abstract] [Full Text] [Related]
10. Betaxolol in patients with glaucoma and asthma.
Van Buskirk EM; Weinreb RN; Berry DP; Lustgarten JS; Podos SM; Drake MM
Am J Ophthalmol; 1986 May; 101(5):531-4. PubMed ID: 3706457
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenoceptors blocking eye drops in patients with chronic bronchitis.
Hugues FC; Matte JC; Le Jeunne C; Salem A
Therapie; 1992; 47(3):211-5. PubMed ID: 1363497
[TBL] [Abstract][Full Text] [Related]
12. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of topical beta-blockers during exercise.
Atkins JM; Pugh BR; Timewell RM
Am J Ophthalmol; 1985 Feb; 99(2):173-5. PubMed ID: 3970121
[TBL] [Abstract][Full Text] [Related]
14. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
[TBL] [Abstract][Full Text] [Related]
15. Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.
Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):682-5. PubMed ID: 7906474
[TBL] [Abstract][Full Text] [Related]
16. Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation.
Yoshida A; Ogasawara H; Fujio N; Konno S; Ishiko S; Kitaya N; Kagokawa H; Nagaoka T; Hirokawa H
Eye (Lond); 1998; 12 ( Pt 5)():848-53. PubMed ID: 10070522
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.
Bauer KG; Brunner-Ferber F; Distlerath LM; Lippa EA; Binkowitz B; Till P; Kaik GA
Br J Clin Pharmacol; 1992 Aug; 34(2):122-9. PubMed ID: 1358158
[TBL] [Abstract][Full Text] [Related]
18. Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol.
Lynch MG; Whitson JT; Brown RH; Nguyen H; Drake MM
Arch Ophthalmol; 1988 Jul; 106(7):908-11. PubMed ID: 2898932
[TBL] [Abstract][Full Text] [Related]
19. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
[TBL] [Abstract][Full Text] [Related]
20. The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers.
Vogel R; Clineschmidt CM; Hoeh H; Kulaga SF; Tipping RW
J Ocul Pharmacol; 1990; 6(2):85-90. PubMed ID: 2394934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
